AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 12/12/19

Amneal Pharmaceuticals (NYSE: AMRX ) +32%  as FDA OKs Amneal ANDA for EluRyng. More news on: Amneal Pharmaceuticals, Inc., LMP Automotive Holdings, Inc., Pintec Technology Holdings Limited, Stocks on the move, Read more ...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for EluRyng™ (etonogestrel/ethinyl estradiol vaginal ...

Amneal Pharmaceuticals (NYSE: AMRX ) and AvKARE Inc. have entered into a definitive agreement under which Amneal will acquire a 65.1% majority interest in AvKARE and its related affiliate doing business as R&S Northeast for an implied enterprise value of $340M. More news on: Amneal P...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) and AvKARE Inc. today announced they have entered into a definitive agreement under which Amneal will acquire a 65.1% majority interest in AvKARE and its related affiliate doing business as R&S Northeast (collectively, “AvKARE”) for ...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received final U.S. Food and Drug Administration approval on its Abbreviated New Drug Application for a generic version of Carafate® (sucralfate) Oral Suspension, 1 g/10 ml. Amneal has immediately initiated commer...

The FDA approves Amneal Pharmaceuticals' (NYSE: AMRX ) generic versions of Pfizer's (NYSE: PFE ) Revatio (sildenafil citrate) Oral Suspension 10 mg/mL and Clover Pharms' Amicar (aminocaproic acid) Tablets USP, 500 mg. Commercialization will begin immediately. More news on: Amneal Pharmac...

- Company granted 180 days of exclusivity under FDA Competitive Generic Therapy approval pathway for Generic Amicar - Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received final U.S. Food and Drug Administration (“FDA”) approval on its Abbre...

Introduction to the Positive/Negative Forensic Value Stock Selections This quantitative study continues a series of multi-year test now using the top four forensic algorithms applied to detect bankruptcy risk, earnings manipulation, and financial irregularities. This forward testing study co...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch t...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...